**Question:** Drug which is not used in glaucoma

**Core Concept:** Glaucoma is a group of eye disorders that lead to progressive damage to the optic nerve and subsequent vision loss. Treatment options aim to lower intraocular pressure (IOP) to protect the optic nerve.

**Why the Correct Answer is Right:**
Drugs used to treat glaucoma fall into two main categories: beta-blockers and prostaglandin analogs. Beta-blockers (e.g., timolol) work by decreasing aqueous humor production, while prostaglandin analogs (e.g., latanoprost) increase outflow of the aqueous humor through the trabecular meshwork.

**Why Each Wrong Option is Incorrect:**
A. **Beta-agonists** (e.g., epinephrine) are used to treat low blood pressure, asthma, and angina. They increase heart rate and contractility, which is counterproductive in lowering intraocular pressure.
B. **Anticholinergics** (e.g., atropine) are used for various conditions like dry eyes, urinary retention, and Parkinson's disease. They inhibit acetylcholine, a neurotransmitter involved in aqueous humor production and outflow, but are not specific to the eye.
C. **Calcium channel blockers** (e.g., amlodipine) are used for hypertension, angina, and migraines. They affect calcium channels in various organs and tissues, but are not specifically targeted for lowering intraocular pressure in glaucoma treatment.
D. **Angiotensin II receptor blockers** (e.g., losartan) are used for hypertension and congestive heart failure. They target the renin-angiotensin-aldosterone system, which is involved in blood pressure regulation, not intraocular pressure management.

**Core Concept:** Treatment options for glaucoma focus on lowering intraocular pressure, as raised IOP is a key risk factor for optic nerve damage in glaucoma.

**Why the Correct Answer is Right:**
The correct answer, Calcium channel blockers (option C), is incorrect for treating glaucoma as they are used to manage conditions unrelated to intraocular pressure control.

**Why Each Wrong Option is Incorrect:**
A. Beta-agonists (option A) are used to treat low blood pressure, asthma, and angina. These drugs increase heart rate and contractility, which is counterproductive in lowering intraocular pressure in glaucoma treatment.
B. Anticholinergics (option B) are used for dry eyes, urinary retention, and migraines. They inhibit acetylcholine, a neurotransmitter involved in aqueous humor production and outflow but are not specifically targeted for lowering intraocular pressure in glaucoma treatment.
C. Calcium channel blockers (option C) are used for hypertension and congestive heart failure. They target the renin-angiotensin-aldosterone system, which is involved in blood pressure regulation, not intraocular pressure management.
D. Angiotensin II receptor blockers (option